Insider trade

Insider sold ~$13.6M of LLY shares in the open market

Traded May 6, 2026 · Filed May 7, 2026

Eli LillyLLY

~$13.6M
Reported value · 14K sh @ $995.225: 91.9M
Holds after · shares reported: +16.5%
stock since the trade · S&P 500 +4.1%, $987.05 → $1,149.85 on Oct 1

Why it stands out

Eli Lilly's Reporting person sold $13.6M of Eli Lilly shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 6, 2026
Reporting period: Not applicable
Filed with the SEC: May 7, 2026

Insider$1M+

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$13,554,965

Shares × reported transaction price

Timing vs results

6 days after results of Apr 30, 2026, 91 days before results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $987.05 on May 6, 2026, 58% above its 52-week low and 11% below its high, after a 9% rise over the previous 30 trading days

52-week range $625.65 (Aug 8, 2025) to $1,109.94 (Nov 25, 2025), 75% of the way up, from 251 adjusted closes. 30 trading days earlier: $903.02 on Mar 24, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+6.0%	+0.2%	+5.7%
30 days	+21.2%	+0.2%	+20.9%
90 days	+25.7%	+4.2%	+21.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0000316011-26-000015
Filed / recorded: May 7, 2026, 8:00 PM UTC
Added to OQRO: Oct 2, 2026, 3:52 AM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: ELI LILLY & Co
Issuer CIK: 59478
Ticker: LLY
Reporting person: LILLY ENDOWMENT INC
Relationship: Other
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: May 6, 2026
Transaction code: S
Shares / units: 13,620
Price per share: $995.225
Acquired / disposed: Disposed (D)
Shares owned after: 91,883,358
Ownership form: Direct
Amendment: No

Footnotes from the filing

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.